What is the use of biopsy and antibodies in coeliac disease diagnosis?

Journal of Internal Medicine

Volumn 269, Issue 6, 2011, Pages 572-581

  Evans, K E ^a   Sanders, D S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Biopsy; Coeliac disease; Diagnosis; Gluten enteropathy; Serology

Indexed keywords

ENDOMYSIUM ANTIBODY; GLIADIN; GLUTEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ALGORITHM; CAPSULE ENDOSCOPY; CELIAC DISEASE; CONFERENCE PAPER; DIAGNOSTIC TEST ACCURACY STUDY; DUODENUM BIOPSY; GLUTEN FREE DIET; HEALTH CARE COST; HLA TYPING; HUMAN; POINT OF CARE TESTING; PRICK TEST; PRIORITY JOURNAL; SERODIAGNOSIS;

ALGORITHMS; AUTOANTIBODIES; BIOLOGICAL MARKERS; BIOPSY; CELIAC DISEASE; DUODENUM; HISTOCOMPATIBILITY TESTING; HUMANS;

EID: 79956273551     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02380.x     Document Type: Conference Paper

References (111)

1. Meeuwisse G. Diagnostic criteria in coeliac disease. Acta Paediatr Scand 1970; 59: 461-3.
2. Swinson CM, Levi AJ. Is coeliac disease underdiagnosed? Br Med J 1980; 281: 1258-60.
3. Green PH, Jabri B. Coeliac disease. Lancet 2003; 362: 383-91.
4. When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol 2001; 13: 1123-8.
5. Weinstein WM. Latent coeliac sprue. Gastroenterology 1974; 66: 489-93.
6. Doherty M, Barry RE. Gluten-induced mucosal changes in subjects without overt small-bowel disease. Lancet 1981; 1: 517-20.
7. Matysiak-Budnik T et al. Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut 2007; 56: 1379-86.
8. Ludvigsson JF et al. Coeliac disease and the risk of fractures - a general population-based cohort study. Aliment Pharmacol Ther 2007; 25: 273-85.
9. Dickey W, Hughes DF, McMillan SA. Patients with serum IgA endomysial antibodies and intact duodenal villi: clinical characteristics and management options. Scand J Gastroenterol 2005; 40: 1240-3.
10. Kaukinen K et al. Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci 2001; 46: 879-87.
11. Mustalahti K et al. Osteopenia in patients with clinically silent coeliac disease warrants screening. Lancet 1999; 354: 744-5.
12. Kaukinen K et al. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Scand J Gastroenterol 2005; 40: 564-72.
13. Ludvigsson JF, Brandt L, Montgomery SM. Symptoms and signs in individuals with serology positive for celiac disease but normal mucosa. BMC Gastroenterol 2009; 9: 57.
14. Scott BB, Losowsky MS. Coeliac disease with mild mucosal abnormalities: a report of four patients. Postgrad Med J 1977; 53: 134-8.
15. Ferguson A, Arranz E, O'Mahony S. Clinical and pathological spectrum of coeliac disease--active, silent, latent, potential. Gut 1993; 34: 150-1.
16. Fraser NG, Ferguson A, Murray D. Dermatitis herpetiformis in two patients with idiopathic steatorrhoea (adult coeliac disease). Br Med J 1968; 4: 30-1.
17. Troncone R et al. Gluten sensitivity in a subset of children with insulin dependent diabetes mellitus. Am J Gastroenterol 2003; 98: 590-5.
18. James SP. This month at the NIH: Final statement of NIH Consensus Conference on celiac disease. Gastroenterology 2005; 128: 6.
19. Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol 2009; 104: 1587-94.
20. Akobeng AK. Understanding diagnostic tests 1: sensitivity, specificity and predictive values. Acta Paediatr 2007; 96: 338-41.
21. Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol 2010; 105: 2520-4.
22. Excellence, N.I.f.H.a.C. Coeliac Disease. Recognition and Assessment of Coeliac Disease. London: National Institute for Health and Clinical Excellence, 2009.
23. Richey R et al. Recognition and assessment of coeliac disease in children and adults: summary of NICE guidance. BMJ 2009; 338: b1684.
24. Toftedal P et al. Positive predictive value of serological diagnostic measures in celiac disease. Clin Chem Lab Med 2010; 48: 685-91.
25. James MW, Scott BB. Endomysial antibody in the diagnosis and management of coeliac disease. Postgrad Med J 2000; 76: 466-8.
26. Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther 2006; 24: 47-54.
27. Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology 2005; 128(4 Suppl 1): S25-32.
28. Naiyer AJ et al. Comparison of commercially available serologic kits for the detection of celiac disease. J Clin Gastroenterol 2009; 43: 225-32.
29. Wong RC et al. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol 2002; 55: 488-94.
30. Rostami K et al. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 1999; 94: 888-94.
31. Rostom A et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005; 128(4 Suppl 1): S38-46.
32. Walker MM et al. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology 2010; 139: 112-9.
33. Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010; 31: 73-81.
34. Basso D et al. Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin Chem 2009; 55: 150-7.
35. Kurppa K et al. Antibodies against deamidated gliadin peptides in early-stage celiac disease. J Clin Gastroenterol 2010. PMID 21063208; Epub ahead of print.
36. Niveloni S et al. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Clin Chem 2007; 53: 2186-92.
37. Volta U et al. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci 2008; 53: 1582-8.
38. Volta U et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol 2010; 44: 186-90.
39. Ferre-Lopez S et al. Immunochromatographic sticks for tissue transglutaminase and antigliadin antibody screening in celiac disease. Clin Gastroenterol Hepatol 2004; 2: 480-4.
40. Baldas V et al. Development of a novel rapid non-invasive screening test for coeliac disease. Gut 2000; 47: 628-31.
41. Raivio T et al. Self transglutaminase-based rapid coeliac disease antibody detection by a lateral flow method. Aliment Pharmacol Ther 2006; 24: 147-54.
42. Raivio T et al. Performance of a new rapid whole blood coeliac test in adult patients with low prevalence of endomysial antibodies. Dig Liver Dis 2007; 39: 1057-63.
43. Raivio T et al. Comparison of a novel whole blood transglutaminase-based ELISA with a whole blood rapid antibody test and established conventional serological celiac disease assays. J Pediatr Gastroenterol Nutr 2008; 47: 562-7.
44. Korponay-Szabo IR et al. Coeliac disease case finding and diet monitoring by point-of-care testing. Aliment Pharmacol Ther 2005; 22: 729-37.
45. Korponay-Szabo IR et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ 2007; 335: 1244-7.
46. Hopper AD et al. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 2007; 334: 729.
47. Tursi A, Brandimarte G, Giorgetti GM. Sorbitol H2-breath test versus anti-endomysium antibodies for the diagnosis of subclinical/silent coeliac disease. Scand J Gastroenterol 2001; 36: 1170-2.
48. Tursi A, Brandimarte G, Giorgetti GM. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol 2003; 36: 219-21.
49. Hopper AD et al. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol 2008; 6: 314-20.
50. Zanini B et al. Five year time course of celiac disease serology during gluten free diet: results of a community based "CD-Watch" program. Dig Liver Dis 2010; 42: 865-70.
51. Hall NJ, Rubin G, Charnock A. Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther 2009; 30: 315-30.
52. Rubio-Tapia A et al. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 2010; 105: 1412-20.
53. Lanzini A et al. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther 2009; 29: 1299-308.
54. Haines ML, Anderson RP, Gibson PR. Systematic review: The evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther 2008; 28: 1042-66.
55. Cataldo F et al. Celiac disease and selective immunoglobulin A deficiency. J Pediatr 1997; 131: 306-8.
56. Latiff AH, Kerr MA. The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem 2007; 44(Pt 2): 131-9.
57. Heneghan MA et al. Celiac sprue and immunodeficiency states: a 25-year review. J Clin Gastroenterol 1997; 25: 421-5.
58. Wahnschaffe U et al. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001; 121: 1329-38.
59. Cataldo F et al. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and "Club del Tenue" Working Groups on Coeliac Disease. Gut 1998; 42: 362-5.
60. Vecchi M et al. High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol 2003; 38: 50-4.
61. Bizzaro N, Pasini P, Finco B. False-positive reactions for IgA anti-phospholipid and anti-beta(2)-glycoprotein I antibodies in patients with IgA monoclonal gammopathy. Clin Chem 1999; 45: 2007-10.
62. Cataldo F et al. IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Coeliac Disease of SIGEP and Club del Tenue. Gut 2000; 47: 366-9.
63. Sugai E et al. Dynamics of coeliac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment. Dig Liver Dis 2010; 42: 352-8.
64. Sorell L et al. One-step immunochromatographic assay for screening of coeliac disease. Lancet 2002; 359: 945-6.
65. Hill PG, Holmes GK. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 2008; 27: 572-7.
66. Sollid LM et al. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989; 169: 345-50.
67. Tosi R et al. Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol 1983; 28: 395-404.
68. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006; 131: 1981-2002.
69. Kaukinen K et al. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol 2002; 97: 695-9.
70. Green PH. Celiac disease: how many biopsies for diagnosis? Gastrointest Endosc 2008; 67: 1088-90.
71. Bonamico M et al. Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives. J Pediatr Gastroenterol Nutr 2006; 42: 150-4.
72. Bourgey M et al. HLA related genetic risk for coeliac disease. Gut 2007; 56: 1054-9.
73. Cassinotti A et al. HLA and autoimmune digestive disease: a clinically oriented review for gastroenterologists. Am J Gastroenterol 2009; 194: 218.
74. Zubillaga P et al. HLA-DQA1 and HLA-DQB1 genetic markers and clinical presentation in celiac disease. J Pediatr Gastroenterol Nutr 2002; 34: 548-54.
75. Dorn SD, Matchar DB. Cost-effectiveness analysis of strategies for diagnosing celiac disease. Dig Dis Sci 2008; 53: 680-8.
76. Chang M, Green PH. Genetic testing before serologic screening in relatives of patients with celiac disease as a cost containment method. J Clin Gastroenterol 2009; 43: 43-50.
77. Mee AS et al. Small bowel biopsy for malabsorption: comparison of the diagnostic adequacy of endoscopic forceps and capsule biopsy specimens. Br Med J (Clin Res Ed) 1985; 291: 769-72.
78. Achkar E et al. Comparison of suction capsule and endoscopic biopsy of small bowel mucosa. Gastrointest Endosc 1986; 32: 278-81.
79. Ravelli A et al. How patchy is patchy villous atrophy?: distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol 2010; 105: 2103-10.
80. Weir DC et al. Variability of histopathological changes in childhood celiac disease. Am J Gastroenterol 2010; 105: 207-12.
81. Macdonald WC et al. Studies of Celiac Sprue. Iv. The Response of the Whole Length of the Small Bowel to a Gluten-Free Diet. Gastroenterology 1964; 47: 573-89.
82. Shidrawi RG et al. Pitfalls in diagnosing coeliac disease. J Clin Pathol 1994; 47: 693-4.
83. Trier JS. Diagnostic value of peroral biopsy of the proximal small intestine. N Engl J Med 1971; 285: 1470-3.
84. Hopper AD, Sanders DS. The duodenal bulb biopsy "myth": is there now enough evidence to change clinical practice? J Clin Gastroenterol 2009; 43: 692.
85. Pais WP et al. How many duodenal biopsy specimens are required to make a diagnosis of celiac disease? Gastrointest Endosc 2008; 67: 1082-7.
86. Corazza GR et al. Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol 2007; 5: 838-43.
87. Evans KE, Sanders DS. Joint BAPEN and British Society of Gastroenterology Symposium on 'Coeliac disease: basics and controversies'. Coeliac disease: optimising the management of patients with persisting symptoms? Proc Nutr Soc 2009; 68: 242-8.
88. Ludvigsson JF et al. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009; 302: 1171-8.
89. Dickey W, Hughes DF, McMillan SA. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one-fifth. Scand J Gastroenterol 2000; 35: 181-3.
90. McMillan SA et al. Predictive value for coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy. BMJ 1991; 303: 1163-5.
91. Collin P et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 2005; 17: 85-91.
92. Salmi TT et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut 2006; 55: 1746-53.
93. Tursi A et al. Low prevalence of antigliadin and anti-endomysium antibodies in subclinical/silent celiac disease. Am J Gastroenterol 2001; 96: 1507-10.
94. Kurppa K et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009; 136: 816-23.
95. Tursi A, Brandimarte G. The symptomatic and histologic response to a gluten-free diet in patients with borderline enteropathy. J Clin Gastroenterol 2003; 36: 13-7.
96. Biagi F et al. The prevalence and the causes of minimal intestinal lesions in patients complaining of symptoms suggestive of enteropathy: a follow-up study. J Clin Pathol 2008; 61: 1116-8.
97. Aziz I et al. A prospective study into the aetiology of lymphocytic duodenosis. Aliment Pharmacol Ther 2010; 12: 1392-7.
98. Wahab PJ et al. Gluten challenge in borderline gluten-sensitive enteropathy. Am J Gastroenterol 2001; 96: 1464-9.
99. Campanella J et al. Clinical response to gluten withdrawal is not an indicator of coeliac disease. Scand J Gastroenterol 2008; 43: 1311-4.
100. Jabbari M et al. Scalloped valvulae conniventes: an endoscopic marker of celiac sprue. Gastroenterology 1988; 95: 1518-22.
101. Brocchi E et al. Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med 1988; 319: 741-4.
102. Magazzu G et al. Upper gastrointestinal endoscopy can be a reliable screening tool for coeliac sprue in adults. J Clin Gastroenterol 1994; 19: 255-7; discussion 257-8.
103. Maurino E et al. Value of endoscopic markers in celiac disease. Dig Dis Sci 1993; 38: 2028-33.
104. Petroniene R et al. Given capsule endoscopy in celiac disease: evaluation of diagnostic accuracy and interobserver agreement. Am J Gastroenterol 2005; 100: 685-94.
105. Hopper AD et al. Capsule endoscopy: an alternative to duodenal biopsy for the recognition of villous atrophy in coeliac disease? Dig Liver Dis 2007; 39: 140-5.
106. Rondonotti E et al. Video capsule enteroscopy in the diagnosis of celiac disease: a multicenter study. Am J Gastroenterol 2007; 102: 1624-31.
107. Biagi F et al. Video capsule endoscopy and histology for small-bowel mucosa evaluation: a comparison performed by blinded observers. Clin Gastroenterol Hepatol 2006; 4: 998-1003.
108. Biagi F et al. The impact of misdiagnosing celiac disease at a referral centre. Can J Gastroenterol 2009; 23: 543-5.
109. Sugai E et al. Celiac disease serology in patients with different pretest probabilities: is biopsy avoidable? World J Gastroenterol 2010; 16: 3144-52.
110. Hill PG, McMillan SA. Anti-tissue transglutaminase antibodies and their role in the investigation of coeliac disease. Ann Clin Biochem 2006; 43(Pt 2): 105-17.
111. Hill PG et al. IgA antibodies to human tissue transglutaminase: audit of routine practice confirms high diagnostic accuracy. Scand J Gastroenterol 2004; 39: 1078-82.